These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 25917204)
1. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Granata V; Fusco R; Piccirillo M; Palaia R; Petrillo A; Lastoria S; Izzo F Int J Surg; 2015 Jun; 18():230-6. PubMed ID: 25917204 [TBL] [Abstract][Full Text] [Related]
2. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. Granata V; Fusco R; Setola SV; Piccirillo M; Leongito M; Palaia R; Granata F; Lastoria S; Izzo F; Petrillo A World J Gastroenterol; 2017 Jul; 23(26):4767-4778. PubMed ID: 28765698 [TBL] [Abstract][Full Text] [Related]
3. Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer. Granata V; Fusco R; Setola SV; Palaia R; Albino V; Piccirillo M; Grimm R; Petrillo A; Izzo F Radiol Oncol; 2019 Jan; 53(1):15-24. PubMed ID: 30681974 [TBL] [Abstract][Full Text] [Related]
4. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma. Bhutiani N; Li Y; Zheng Q; Pandit H; Shi X; Chen Y; Yu Y; Pulliam ZR; Tan M; Martin RCG Ann Surg Oncol; 2020 Oct; 27(11):4348-4359. PubMed ID: 32681477 [TBL] [Abstract][Full Text] [Related]
5. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Nywening TM; Wang-Gillam A; Sanford DE; Belt BA; Panni RZ; Cusworth BM; Toriola AT; Nieman RK; Worley LA; Yano M; Fowler KJ; Lockhart AC; Suresh R; Tan BR; Lim KH; Fields RC; Strasberg SM; Hawkins WG; DeNardo DG; Goedegebuure SP; Linehan DC Lancet Oncol; 2016 May; 17(5):651-62. PubMed ID: 27055731 [TBL] [Abstract][Full Text] [Related]
6. Electrochemotherapy for advanced cutaneous angiosarcoma: A European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT). Campana LG; Kis E; Bottyán K; Orlando A; de Terlizzi F; Mitsala G; Careri R; Curatolo P; Snoj M; Sersa G; Valpione S; Quaglino P; Mowatt D; Brizio M; Schepler H Int J Surg; 2019 Dec; 72():34-42. PubMed ID: 31618680 [TBL] [Abstract][Full Text] [Related]
7. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P Oncology; 2015; 89(1):37-46. PubMed ID: 25766660 [TBL] [Abstract][Full Text] [Related]
8. Safety and Feasibility of Electrochemotherapy of the Pancreas in a Porcine Model. Dežman R; Čemažar M; Serša G; Seliškar A; Erjavec V; Trotovšek B; Gašljevič G; Bošnjak M; Lampreht Tratar U; Kos B; Djokić M; Milevoj N; Štukelj M; Boc N; Izlakar J; Popovič P Pancreas; 2020 Oct; 49(9):1168-1173. PubMed ID: 32898000 [TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332 [TBL] [Abstract][Full Text] [Related]
10. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience. Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368 [TBL] [Abstract][Full Text] [Related]
11. FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning. Levy A; Chargari C; Huguet F; Védrine L; Deutsch E Pancreas; 2012 Aug; 41(6):973-4. PubMed ID: 22781912 [No Abstract] [Full Text] [Related]
12. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Stein SM; James ES; Deng Y; Cong X; Kortmansky JS; Li J; Staugaard C; Indukala D; Boustani AM; Patel V; Cha CH; Salem RR; Chang B; Hochster HS; Lacy J Br J Cancer; 2016 Mar; 114(7):737-43. PubMed ID: 27022826 [TBL] [Abstract][Full Text] [Related]
13. Electrochemotherapy guided by intraoperative fluorescence imaging for the treatment of inoperable peritoneal micro-metastases. Josserand V; Kéramidas M; Lavaud J; Righini C; Vollaire J; Bellard E; Rols MP; Teissié J; Coll JL; Golzio M J Control Release; 2016 Jul; 233():81-7. PubMed ID: 27155365 [TBL] [Abstract][Full Text] [Related]
14. Electrochemotherapy - possible benefits and limitations to its use in the head and neck region. Landström FJ; Reizenstein JA; Nilsson CO; Beckerath MV; Löfgren AL; Adamsson GB; Möller C Acta Otolaryngol; 2015 Jan; 135(1):90-5. PubMed ID: 25496181 [TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy with intravenous bleomycin for advanced non-melanoma skin cancers and for cutaneous and subcutaneous metastases from melanoma. Tomassini GM; Covarelli P; Tomassini MA; Corsi A; Bianchi L; Hansel K; Stingeni L G Ital Dermatol Venereol; 2016 Oct; 151(5):499-506. PubMed ID: 27595201 [TBL] [Abstract][Full Text] [Related]
16. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience. Casadei R; Ricci C; Ingaldi C; Alberici L; Di Marco M; Guido A; Minni F; Serra C Updates Surg; 2020 Dec; 72(4):1089-1096. PubMed ID: 32399592 [TBL] [Abstract][Full Text] [Related]
17. Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary study. Perrone AM; Galuppi A; Cima S; Pozzati F; Arcelli A; Cortesi A; Procaccini M; Pellegrini A; Zamagni C; De Iaco P Gynecol Oncol; 2013 Sep; 130(3):550-3. PubMed ID: 23811116 [TBL] [Abstract][Full Text] [Related]